Novartis acquires biotech firm DTx Pharma to gain access to FALCON platform
Swiss pharmaceutical giant Novartis has acquired DTx Pharma, a preclinical stage biotechnology company based in California renowned for its Fatty Acid Ligand Conjugated OligoNucleotide (FALCON) platform, which addresses the delivery challenges of oligonucleotide therapeutics. This acquisition, including the revolutionary FALCON platform, will enhance the delivery of small interfering RNA (siRNA) therapeutics to tissues beyond the […]